InvestorsHub Logo
Followers 24
Posts 883
Boards Moderated 0
Alias Born 02/28/2017

Re: St George post# 25874

Tuesday, 02/04/2020 2:27:15 AM

Tuesday, February 04, 2020 2:27:15 AM

Post# of 54914
All will become clear grasshopper in the not too distant future but one would have to suspect it has zero to do with management and more to do with the database of markers which would ensure that patients who were within a certain genetic demographic would be more suitable for treatment vs others.

Secret is in the name “predictive”

Future medicine will be individual based not mass treatments with one size fits all. PREDs genetic data base is what is the real asset here. 300000 disease data points across multiple diseases/illnesses is what makes the company special.

That’s why atrin are here, not that complicated Georgie boy

PS
Spoke to HFC yesterday, a large number of patients used Artguide with a high number of successful outcomes. Data to appear shortly according to the lady I spoke to. Stay tuned

Also I’m not saying Robinson is the best ceo in the work by a long shot but I believe their data base is game changing and that’s where the real money will be. That’s why companies like atrin are here and I suspect more to follow.